Extended Data Fig. 10: Activation of aDCN neurons robustly increases striatal dopamine signalling that correlates with reduced food intake. | Nature

Extended Data Fig. 10: Activation of aDCN neurons robustly increases striatal dopamine signalling that correlates with reduced food intake.

From: Reverse-translational identification of a cerebellar satiation network

Extended Data Fig. 10

(a) Schematic depicting hM3D(Gq) expression in the DCN combined with GRABDA expression41 and fibre implant in the ventral striatum which receives projections from the ventral tegmental area (VTA) dopamine (DA) neurons64,65. (b) GRABDA expression and fibre placement in the ventral striatum. Scale bar, 1000 µm. (c, d) Average ∆F/F of GRABDA signals in the ventral striatum of food-deprived mCherry control (c) or aDCN-LAT hM3D(Gq) (d) mice treated with vehicle or CNO. Signals are aligned to the vehicle or CNO injection (red line). Dark line represents the mean and lighter shaded area represents SEMs. Corresponding heatmaps (right) depict ∆F/F of GRABDA signals in each mouse (n = 6 control mice, grey; n = 6 hM3D(Gq) aDCN-LAT mice, green). (e) Average ∆F/F of GRABDA signals in 3-min bins (n = 6 control mice, grey; n = 6 hM3D(Gq) aDCN-LAT mice, repeated measures two-way ANOVA interaction P < 0.001, main effect P < 0.001; Holm-Sidak’s, P = 0.027/ = 0.397/=0.625 (12-15 min), P < 0.001/<0.001/ < 0.001 (15-18 min), P < 0.001/<0.001/ < 0.001 (18-21 min), P<0.001/ < 0.001/ < 0.001 (21-24 min), P < 0.001/ < 0.001/ < 0.001 (24-27 min), P < 0.001/ < 0.001/ < 0.001 (27-30 min), hM3D(Gq) CNO to hM3D(Gq) vehicle/control CNO/control vehicle respectively). (f) Maximum ∆F/F of GRABDA signals in the ventral striatum of vehicle or CNO treated food-deprived mice with aDCN-LAT hM3D(Gq) (n = 6, paired t-test, P = 0.011). (g) Mean ∆F/F of GRABDA signals in the ventral striatum (n = 6, paired t-test, P = 0.002). (h) Maximum ∆F/F of GRABDA signals in the ventral striatum of vehicle or CNO treated food-deprived mice with aDCN mCherry control mice (n = 6, paired t-test, P = 0.242). (i) Mean ∆F/F of GRABDA signals in the ventral striatum of vehicle or CNO treated food-deprived mice with aDCN mCherry control mice (n = 6, paired t-test, P = 0.418). (j) Scatter plot comparing changes in GRABDA signals to amount of chow consumed in 1 h following activation of the aDCN in hM3D(Gq)-expressing mice treated with CNO (n = 13, Pearson correlation). (k) Average ∆F/F of GRABDA signals in the ventral striatum of food-deprived aDCN-INT hM3D(Gq) mice treated with vehicle or CNO. Signals are aligned to the vehicle or CNO injection (red line). Dark line represents the mean and lighter shaded area represents SEMs. Corresponding heatmaps (right) depict ∆F/F of GRABDA signals in each mouse (n = 7). (l) Average ∆F/F of GRABDA signals in 3-min bins following vehicle or CNO treatment of the aDCN-INT with hM3D(Gq) (n = 7, repeated measures two-way ANOVA interaction P = 0.301). (m) Maximum ∆F/F of GRABDA signals in the ventral striatum of vehicle or CNO treated food-deprived mice with aDCN-INT hM3D(Gq) mice (n = 7, paired t-test, P = 0.410). (n) Mean ∆F/F of GRABDA signals in the ventral striatum of vehicle or CNO treated food-deprived mice with aDCN-INT hM3D(Gq) mice (n = 7, paired t-test, P = 0.367). Data are expressed as mean ± SEM, two-sided P values, t-tests and post-hoc comparisons: *P < 0.05, **P < 0.01, ***P < 0.001; ANOVA interaction: ∞∞∞P < 0.001; ANOVA main effect of group: ¤¤¤P < 0.001. Statistical analysis in Supplementary Table 1

Source data.

Back to article page